Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
常通口服液预防手术后腹腔粘连安全性和有效性的多中心、随机、双盲、安慰剂平行对照、IIIa期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase IIIa clinical trial on the safety and efficacy of Changtong oral liquid in preventing postoperative abdominal adhesions
评价常通口服液用于腹部手术患者术后预防腹膜粘连的安全性与有效性。
[Translation] To evaluate the safety and effectiveness of Changtong oral liquid in preventing peritoneal adhesions in patients undergoing abdominal surgery.
常通口服液防治手术后腹膜粘连的有效性和安全性Ⅱ期 临床试验
[Translation] Phase II clinical trial on the effectiveness and safety of Changtong oral liquid in preventing and treating postoperative peritoneal adhesions
1.评价常通口服液用于单纯性阑尾炎、急性化脓性阑尾炎、慢性阑尾炎或因子宫肌瘤而行腹式全子宫切除术、腹式子宫次全切术的腹部手术患者术后腹膜粘连的临床防治效果。 2.评价常通口服液用于腹部手术患者术后腹膜粘连的安全性与不良反应。
[Translation] 1. To evaluate the clinical efficacy of Changtong oral liquid in the prevention and treatment of postoperative peritoneal adhesion in patients with simple appendicitis, acute suppurative appendicitis, chronic appendicitis, or abdominal hysterectomy or subtotal abdominal hysterectomy due to uterine fibroids. 2. To evaluate the safety and adverse reactions of Changtong oral liquid in the treatment of postoperative peritoneal adhesion in patients with abdominal surgery.
100 Clinical Results associated with The First Military Medical University of the Chinese People's Liberation Army
0 Patents (Medical) associated with The First Military Medical University of the Chinese People's Liberation Army
100 Deals associated with The First Military Medical University of the Chinese People's Liberation Army
100 Translational Medicine associated with The First Military Medical University of the Chinese People's Liberation Army